查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1657988

印度的手術中放射線治療市場評估:產品·各類服務，各技術，各用途，各終端用戶，各地區，機會及預測，2018～2032年

India Intraoperative Radiation Therapy Market Assessment, By Products and Services, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, FY2018-FY2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 134 Pages | 商品交期: 3-5個工作天內

價格

印度術中放射治療市場預計將從 2024 年的 159 萬美元增長到 2032 年的 283 萬美元，在預測期內（2025-2032 年）的複合年增長率為 7.50%。市場的成長得益於該國癌症患者數量的增加、研發活動的投資增加、對升級醫療保健行業的日益關注以及主要公司加強提供先進的治療解決方案。此外，印度政府正在積極投資升級癌症治療設施和醫療保健基礎設施，以確保患者能夠獲得先進的治療和服務並改善治療效果。此外，醫療專業人員和目標患者群體對術中放射治療的認識不斷提高，也有助於該技術得到更廣泛的接受。

同時，全國各地各醫院也加緊努力，確保新術中放射治療能普及。例如，2024年5月，卡納塔克邦班加羅爾的Ramaiah紀念醫院透過術中放療X光機，在手術切除後一次性對腫瘤床進行精準的術中放療，成功實施了兩例保乳癌症手術。術中放射治療已成為一種有希望的選擇，可以最大限度地減少長期外照射放射治療的需要。此療法與乳房保留手術結合，可為早期乳癌患者提供有效、精準的治療，改善患者預後，減少放射治療的需要。

此外，印度領先的醫療保健和研究機構正在越來越多地合作開發具有成本效益和創新性的術中放射治療解決方案，以確保更多患者能夠獲得必要的治療選擇。這些措施預計將促進印度的技術創新，並為印度術中放射治療市場提供豐厚的成長機會。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 印度的手術中放射線治療市場預測，2018年～2032年

  • 市場規模的分析與預測
    • 各金額
  • 市場佔有率分析與預測
    • 產品·各類服務
      • 產品
      • 服務
    • 各技術
      • 電子IORT
      • 手術中近接治療
    • 各用途
      • 乳癌
      • 腦瘤
      • 消化器官癌症
      • 頭頸椎癌症
      • 大腸癌症
      • 子宮頸癌症
      • 肺癌症
      • 其他的癌症的種類
    • 各終端用戶
      • 醫院
      • 專門診所
      • 其他
    • 各地區
      • 北部
      • 東部
      • 南部
      • 西部和中央部
    • 市場佔有率分析(前五名公司以及其他- 各金額，2024年)，各企業
  • 市場地圖分析，2024年
    • 產品·各類服務
    • 各技術
    • 各用途
    • 各終端用戶
    • 各地區

第5章 需求供給分析

第6章 價值鏈分析

第7章 波特的五力分析

第8章 大環境分析

第9章 價格分析

第10章 市場動態

  • 推動市場要素
  • 市場課題

第11章 市場趨勢與發展

第12章 法規結構和革新

  • 臨床試驗
  • 法規當局的認證

第13章 專利的形勢

第14章 案例研究

第15章 競爭情形

  • 前五名市場領導公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大市場主要企業的形勢
    • Elekta Medical Systems India Pvt. Ltd.
      • 公司概要
      • 主要經營團隊
      • 產品和服務
      • 財務狀況(如報告)
      • 主要市場焦點和地理存在感
      • 最近的趨勢/合作/夥伴關係/合併和收購
    • Becton Dickinson India Private Limited
    • Sensus Healthcare, Inc.
    • Panacea Medical Technologies Pvt. Ltd.
    • Carl Zeiss AG
    • Eckert &Ziegler SE
    • Sordina IORT Technologies SpA
    • Ariane Medical Systems Ltd.
    • Varian Medical Systems, Inc.

上述公司不依市場佔有率排序，並且可能會根據研究工作期間獲得的資訊進行更改。

第16章 策略性建議

第17章 關於調查公司·免責聲明

Product Code: MX12770

India intraoperative radiation therapy market is projected to witness a CAGR of 7.50% during the forecast period FY2025-FY2032, growing from USD 1.59 million in FY2024 to USD 2.83 million in FY2032. The market's growth is supported by the rising cases of cancer in the country, increasing investments in research and development activities, growing focus on the upgradation of the healthcare sector, and increasing efforts of the leading healthcare companies to boost the availability of advanced treatment solutions. Additionally, the government of India is proactively investing in the upgradation of cancer treatment facilities and healthcare infrastructure to ensure that the patient population has access to advanced care, services, and treatment outcomes are improved. Furthermore, the growing awareness about intraoperative radiation therapies among healthcare professionals and target patient populations is contributing to the increasing acceptance of technology.

Meanwhile, various hospitals across the country are also strengthening their efforts to ensure the availability of novel intraoperative radiation therapies. For instance, in May 2024, Ramaiah Memorial Hospital in Bangalore, Karnataka, successfully conducted two breast conservation cancer surgeries and used an intraoperative radiation therapy x-ray device for delivering precision intraoperative radiation therapy to tumor bed in a single sitting following the surgical resection. Intraoperative radiation therapy has emerged as a promising option for minimizing the requirement for prolonged external beam radiation therapy. The therapy in combination with breast conservation surgery provides effective and precise treatment for patients suffering from early-stage breast cancer, improving patient outcomes and reducing the requirement for radiation therapy.

Furthermore, leading Indian healthcare organizations and research institutions are increasingly collaborating for creating cost-efficient and innovative intraoperative radiation therapy solutions, to ensure that a wider group of patients has access to the necessary treatment options. Such efforts are expected to foster innovation in the country and provide lucrative growth opportunities to the India intraoperative radiation therapy market.

Rapid Adoption of Novel Treatment Solutions by Hospitals to Bolster Market Demand

Hospitals and medical centers across the country are increasingly investing towards advanced technologies such as intraoperative radiation therapy procedures to ensure accurate delivery of radiation during surgical procedures, thus enhancing treatment effectiveness by minimizing damage across the surrounding healthy tissues.

For instance, in June 2023, Fortis Hospital in Bangalore successfully conducted India's first novel intraoperative radiation therapy procedure on a patient suffering from recurrent glioblastoma for the past two years. The increasing awareness about the availability of such advanced therapeutic solutions among both healthcare professionals and patients is expected to bolster the India intraoperative radiation therapy market demand.

Increasing Investments in Radiation Therapy Support Market Expansion

Various leading medical institutes in the country are significantly investing towards radiation therapy systems boosting the India intraoperative radiation therapy market size. In November 2023, the Krishna Institute of Medical Sciences in Hyderabad, Telangana ordered a radiation therapy system worth USD 40 million from Elekta Medical Systems India Pvt. Ltd. The available software and devices allow the institute of medical sciences to provide cutting-edge technologies to the patient population and provide them with precise and personalized treatment solutions. Such investments enable medical professionals to ameliorate the quality of life of patients suffering from chronic conditions, ensuring that they are provided with the best possible care available. Thus, bolstering the demand for intraoperative radiation therapy products and services and positively influencing the market's expansion.

Electron IORT to Register Significant Market Growth in the Future

Electron IORT delivers radiation directly to the tumor site during surgery, ensuring precise targeting of malignant tissues while preserving adjacent healthy tissues. This focused method reduces collateral damage, making it particularly beneficial for treating tumors in sensitive areas such as the breast and gastrointestinal tract. One of the major benefits of electron IORT is the reduction in overall treatment duration. By administering radiation during surgery, patients can avoid numerous post-operative radiation sessions. This efficiency is advantageous for both healthcare providers and patients, promoting faster recovery and shorter hospital stays. Clinical studies indicate that electron IORT can result in better local disease control and lower recurrence rates compared to conventional external beam radiation therapy. The ability to deliver a high dose of radiation accurately during surgery improves treatment effectiveness, contributing to its increasing popularity and supporting the expansion of the segment. Growing awareness among healthcare professionals coupled with rising adoption of this treatment in healthcare facilities to drive the segment growth in the market.

Breast Cancer Anticipated to Hold Significant Market Share

The rising prevalence of breast cancer is augmenting the requirement for advanced therapeutic solutions including intraoperative radiation therapies in the country. According to an article published in Cancer (an international interdisciplinary journal of the American Cancer Society) in January 2024, breast cancer is the most common type of cancer in India among women and accounts for around 25% of all cancers in the female population in the country.

Moreover, according to the Globocan (Global Cancer Repository of WHO) data, there were 192,020 breast cancer cases diagnosed in India. Intraoperative radiation therapy has the advantage of potentially reducing non-compliance to post-operative radiation by delivering a single dose at the time of surgery. The therapy offers various benefits to women with breast cancer that have progesterone and estrogen-receptor-positive tumor and provides effective outcomes by eliminating cancer cells immediately after the surgical procedure. Additionally, the radiation is delivered throughout one small session, ensuring the completion of the treatment at a significantly faster rate than traditional radiation.

Future Market Scenario (FY2025 - FY2032F)

According to India intraoperative radiation therapy market analysis, the market is expected to witness a significant increase in demand in the coming years due to the rising cases of cancer, increasing investments towards the enhancement of healthcare facilities, and growing public awareness about the various treatments available. As per the estimates of the Global Cancer Observatory (Globocan), cancer cases in India will increase by 57.5% between 2040 and 2020.

Integration of advanced technologies such as machine learning and artificial intelligence with intraoperative radiation therapy systems is expected to aid the healthcare industry in increasing the accessibility of treatment solutions in the country.

Increasing collaborations between leading players of the market and global healthcare organizations are anticipated to ensure the development of advanced technological solutions, enhancing the quality of care provided to the patient population.

Investments in training medical professionals would be essential to ensure that they are equipped with the necessary skills to operate advanced technological solutions.

The rising number of multispecialty hospitals in the country is expected to bolster the demand for advanced oncology techniques, further providing lucrative growth opportunities to the India intraoperative radiation therapy market.

Key Players Landscape and Outlook

Leading integrated healthcare companies in the country are increasingly working on implementing intraoperative radiation therapies, providing lucrative growth opportunities for the market.

In October 2024, Aster DM Healthcare Limited became the first in the country to implement intraoperative electron, making a significant shift in cancer care. By targeting remaining microscopic cancer cells in quick succession with the tumor removal process, the chances of survival increase significantly along with recovery time. Such efforts to bolster the availability of advanced treatment solutions in India are expected to aid the country in combatting the growing threat of cancer and positively influence the market's expansion.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Intraoperative Radiation Therapy Market Outlook, FY2018-FY2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Products and Services
      • 4.2.1.1. Products
        • 4.2.1.1.1. Systems/Accelerators
        • 4.2.1.1.2. Applicators and Afterloaders
        • 4.2.1.1.3. Treatment Planning Systems
        • 4.2.1.1.4. Accessories
      • 4.2.1.2. Services
    • 4.2.2. By Technology
      • 4.2.2.1. Electron IORT
      • 4.2.2.2. Intraoperative Brachytherapy
    • 4.2.3. By Application
      • 4.2.3.1. Breast Cancer
      • 4.2.3.2. Brain Tumor
      • 4.2.3.3. Gastrointestinal Cancer
      • 4.2.3.4. Head and Neck Cancer
      • 4.2.3.5. Colorectal Cancer
      • 4.2.3.6. Cervical Cancer
      • 4.2.3.7. Lung Cancer
      • 4.2.3.8. Other Cancer Types
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Specialty Clinics
      • 4.2.4.3. Others
    • 4.2.5. By Region
      • 4.2.5.1. North
      • 4.2.5.2. East
      • 4.2.5.3. South
      • 4.2.5.4. West and Central
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
  • 4.3. Market Map Analysis, FY2024
    • 4.3.1. By Products and Services
    • 4.3.2. By Technology
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

  • 10.1. Market Drivers
  • 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

  • 12.1. Clinical Trials
  • 12.2. Regulatory Approvals

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

  • 15.1. Competition Matrix of Top 5 Market Leaders
  • 15.2. SWOT Analysis for Top 5 Players
  • 15.3. Key Players Landscape for Top 10 Market Players
    • 15.3.1. Elekta Medical Systems India Pvt. Ltd.
      • 15.3.1.1. Company Details
      • 15.3.1.2. Key Management Personnel
      • 15.3.1.3. Products and Services
      • 15.3.1.4. Financials (As Reported)
      • 15.3.1.5. Key Market Focus and Geographical Presence
      • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 15.3.2. Becton Dickinson India Private Limited
    • 15.3.3. Sensus Healthcare, Inc.
    • 15.3.4. Panacea Medical Technologies Pvt. Ltd.
    • 15.3.5. Carl Zeiss AG
    • 15.3.6. Eckert & Ziegler SE
    • 15.3.7. Sordina IORT Technologies S.p.A.
    • 15.3.8. Ariane Medical Systems Ltd.
    • 15.3.9. Varian Medical Systems, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. India Intraoperative Radiation Therapy Market, By Value, In USD Million, FY2018-FY2032F
  • Figure 2. India Intraoperative Radiation Therapy Market Share (%), By Products and Services, FY2018-FY2032F
  • Figure 3. India Intraoperative Radiation Therapy Market Share (%), By Technology, FY2018-FY2032F
  • Figure 4. India Intraoperative Radiation Therapy Market Share (%), By Application, FY2018-FY2032F
  • Figure 5. India Intraoperative Radiation Therapy Market Share (%), By End-user, FY2018-FY2032F
  • Figure 6. India Intraoperative Radiation Therapy Market Share (%), By Region, FY2018-FY2032F
  • Figure 7. By Products and Services Map-Market Size (USD Million) & Growth Rate (%), FY2024
  • Figure 8. By Technology Map-Market Size (USD Million) & Growth Rate (%), FY2024
  • Figure 9. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
  • Figure 10. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
  • Figure 11. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024